Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Double Rainbow Biosciences develops sustainable medicines by harnessing genomics, metabolomics, and synthetic biology to produce high-value natural products at scale. Their lead achievement includes the world’s first commercial-scale biosynthetic production of gastrodin—a natural analgesic with applications in pain management and mental health. The company also collaborates with partners to explore new therapeutics such as kavalactones for mental health and substance use disorders. Their proprietary HARMONY platform enables the decoding and sustainable recreation of complex bioactive molecules from nature.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DF Rainbow.